Compare EOLS & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | LWAY |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.0M | 513.4M |
| IPO Year | 2018 | 1987 |
| Metric | EOLS | LWAY |
|---|---|---|
| Price | $6.85 | $23.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $20.80 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 1.4M | 103.3K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | ★ $285,823,000.00 | $204,069,000.00 |
| Revenue This Year | $14.36 | $15.79 |
| Revenue Next Year | $23.27 | $13.17 |
| P/E Ratio | ★ N/A | $32.38 |
| Revenue Growth | ★ 15.10 | 12.14 |
| 52 Week Low | $5.71 | $19.50 |
| 52 Week High | $17.12 | $34.20 |
| Indicator | EOLS | LWAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 47.28 |
| Support Level | $6.36 | $23.74 |
| Resistance Level | $7.15 | $25.08 |
| Average True Range (ATR) | 0.29 | 1.23 |
| MACD | -0.03 | 0.27 |
| Stochastic Oscillator | 55.74 | 68.69 |
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.